What is the typical sequence of steps for administering general anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steps of General Anesthesia Administration

General anesthesia follows a standardized sequence: preoperative assessment and preparation, induction, maintenance, emergence, and recovery monitoring, with each phase requiring specific interventions and continuous physiologic monitoring. 1

Preoperative Phase

Conduct a focused assessment targeting cardiovascular risk factors, previous anesthetic complications, medication interactions, and fasting status rather than routine screening protocols. 2, 3

  • Review medical history specifically for cardiovascular disease, respiratory conditions, allergies, previous anesthetic reactions, and family history of anesthetic complications 4, 3
  • Assess current medications for potential interactions, particularly MAO inhibitors (avoid meperidine/ephedrine), serotonergic agents, and anticoagulants 5
  • Verify fasting times: 2 hours for clear liquids, 4 hours for breast milk, 6 hours for formula/light meals, and 8+ hours for fatty foods 1
  • Establish baseline vital signs and ensure appropriate monitoring equipment is available (ECG, pulse oximetry, blood pressure, capnography) 2
  • Prepare standardized medication trays with single concentrations per drug, proper ISO 26825 color-coded labels, and documentation of preparation time and personnel 6

Induction Phase

Administer induction agents in small incremental doses or by infusion while establishing airway control and initiating continuous monitoring. 1

  • Begin continuous monitoring (ECG, pulse oximetry, blood pressure, capnography) before administering any medications 2, 1
  • Establish intravenous access and maintain it throughout the procedure until cardiorespiratory depression risk has resolved 1
  • Administer induction agents (propofol, ketamine, sevoflurane) in titrated doses, allowing sufficient time between doses to assess peak effect before subsequent administration 1
  • Secure the airway through one of three methods: endotracheal intubation, laryngeal mask airway, or maintenance of spontaneous ventilation with airway support 1
  • Administer 100% oxygen and ensure adequate ventilation is established 1

Maintenance Phase

Maintain anesthesia depth using inhalational agents or intravenous medications while continuously monitoring vital signs and adjusting to surgical stimulation. 1

  • Continue anesthesia with volatile agents (sevoflurane) or intravenous drugs (propofol, remifentanil) either alone or in combination 1
  • Record vital signs, oxygen saturation, and expired carbon dioxide values at minimum every 10 minutes in a time-based record 1
  • Monitor for signs of inadequate anesthesia depth or excessive depression requiring intervention 1
  • Maintain vascular access and ensure immediate availability of reversal agents (naloxone for opioids, flumazenil for benzodiazepines) 1
  • Have emergency equipment immediately accessible including suction, bag-valve-mask, supraglottic devices, and resuscitation medications 1

Emergence Phase

Discontinue anesthetic agents and support the patient through return of consciousness while maintaining airway patency and adequate ventilation. 1

  • Reduce or discontinue maintenance anesthetics based on surgical completion and patient response 1
  • Continue 100% oxygen supplementation and monitor for respiratory depression or airway obstruction 1
  • If hypoxemia, hypoventilation, or apnea develops: (1) encourage or physically stimulate deep breathing, (2) administer supplemental oxygen, (3) provide positive pressure ventilation if spontaneous ventilation is inadequate 1
  • Administer reversal agents only when airway control, spontaneous ventilation, or positive pressure ventilation is inadequate 1
  • Maintain continuous monitoring until the patient demonstrates purposeful response to verbal commands or tactile stimulation 1

Recovery Phase

Observe the patient in a properly equipped recovery area with continuous monitoring until discharge criteria are met. 1

  • Transfer to recovery area with functioning suction, capacity to deliver >90% oxygen, positive-pressure ventilation equipment, and age-appropriate rescue devices 1
  • Continue vital sign monitoring every 10-15 minutes with continuous oxygen saturation and heart rate monitoring until fully alert 1
  • Maintain NPO status for up to one hour after local anesthetic application to the airway due to depressed laryngeal reflexes and aspiration risk 1
  • Document cardiovascular and respiratory stability, level of consciousness, and orientation before discharge 1
  • Consider extended observation or step-down monitoring for patients receiving long half-life sedatives with re-sedation risk 1

Critical Safety Protocols Throughout All Phases

Implement standardized medication preparation, labeling, and error prevention systems at every step. 6

  • Read medication information aloud twice before preparing syringes for neuraxial procedures 6
  • Use only colored antiseptics to prevent confusion with injectable anesthetics or saline 6
  • Avoid placing antiseptics and injectable anesthetics in similar sterile cups during neuraxial procedures due to high confusion risk 6
  • Calculate maximum safe doses of local anesthetics before administration: lidocaine 7.0 mg/kg with epinephrine (4.4 mg/kg without), bupivacaine 3.0 mg/kg with epinephrine (2.5 mg/kg without) 6
  • Have direct-acting vasopressors (phenylephrine, norepinephrine) immediately available for hemodynamic management 5

Common Pitfalls to Avoid

  • Never administer meperidine to patients on MAO inhibitors due to fatal serotonin syndrome risk 5
  • Never use indirect sympathomimetics (ephedrine) in MAO inhibitor patients due to hypertensive crisis risk; use direct-acting agents instead 5
  • Recognize that drug combinations (sedatives plus opioids) cause synergistic respiratory depression requiring dose reduction of each component and continuous respiratory monitoring 6
  • Do not delay resuscitation to obtain laboratory samples during anaphylactic reactions; obtain mast cell tryptase samples after stabilization 1
  • Avoid assuming adequate ventilation based solely on oxygen saturation; capnography is essential for detecting hypoventilation before desaturation occurs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pre-Procedural ECG Assessment for ENT Surgery Under General Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preoperative assessment.

Lancet (London, England), 2003

Research

Preoperative assessment and premedication in paediatrics.

European journal of anaesthesiology, 2013

Guideline

Anesthesia Care for Patients on MAO Inhibitors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Safe Anesthesia Practice Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the guidelines for anesthesia management in a patient undergoing surgery, considering their medical history, current health status, and potential risks?
What are the pre-operative clearance requirements for a patient undergoing a nasal biopsy under 1 hour of general anesthesia?
What are the benefits of a pre-anesthetic check-up in patients about to undergo surgery under anesthesia?
What approach should be taken for an anesthesia interview for a patient with a history of pre-existing conditions, allergies, and previous surgeries, who is currently on medications and has undergone relevant laboratory tests, undergoing surgery at a hospital?
What is the recommended anesthesia regimen for patients undergoing surgery?
What are the indications for initiating antiviral therapy in chronic hepatitis B and what are the recommended first‑line treatment options?
What is the optimal design for a small (30‑50 adult) study of a therapeutic intervention or diagnostic tool in liver cirrhosis patients stratified as compensated (Child‑Pugh A) and decompensated (Child‑Pugh B‑C), including inclusion/exclusion criteria, primary endpoints such as Model for End‑Stage Liver Disease (MELD) score, bilirubin, albumin, and decompensation events, secondary endpoints like quality‑of‑life scores, dosing regimen, and safety monitoring?
Is the rise in parathyroid hormone a normal physiological adaptation during pregnancy?
Should a person with long COVID (post‑acute sequelae of SARS‑CoV‑2 infection) receive a COVID‑19 vaccine?
In a term infant weighing 3.16 kg with neonatal abstinence syndrome, is an oral morphine sulfate dose of 0.06 mg/kg every 3 hours appropriate, and what total milliliters per day should be administered based on the solution concentration?
What is the appropriate treatment for acute bronchitis in an otherwise healthy adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.